Daniel Fort

Prof/Mgr

Ochsner Health System

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Fort is a Professor and Manager at Ochsner Health System in the United States. His research areas encompass cancer disparities across populations, pediatric gastrointestinal outcomes related to COVID-19, and precision stroke care models. Additionally, he has contributed to studies on T-cell epitope diversity associated with COVID-19 severity, chronic kidney disease guidelines adherence, and the long-term impacts of respiratory conditions following COVID-19 infections.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (2)

Tabitha Harrison

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Ajay Rao

Associate Professor of Medicine

Lewis Katz School of Medicine at Temple University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Fort

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The Translational Research Program in Cancer Differences across Populations

Pediatric Gastrointestinal Tract Outcomes during the Postacute Phase of COVID-19

Precision in Stroke Care: Novel Model for Predicting Functional Independence in Urgent Carotid Intervention Patients

A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population

Concordance with Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes

Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program

Four-year follow-up of weight loss maintenance using electronic medical record data: The PROPEL trial

Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma

Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization – Implications in treatment outcomes

Risk of healthcare visits from influenza in subjects with diabetes and impacts of early vaccination

Collaborators (2)

Tabitha Harrison

Ajay Rao

Make your next move.